ArticleCancer management and research2019

EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.

Lin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.